166 related articles for article (PubMed ID: 32526993)
1. Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.
Michlewska S; Ionov M; Szwed A; Rogalska A; Sanz Del Olmo N; Ortega P; Denel M; Jacenik D; Shcharbin D; de la Mata FJ; Bryszewska M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526993
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium dendrimers against acute promyelocytic leukemia:
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells.
Michlewska S; Maroto M; Hołota M; Kubczak M; Sanz Del Olmo N; Ortega P; Shcharbin D; de la Mata FJ; Bryszewska M; Ionov M
Dalton Trans; 2021 Jul; 50(27):9500-9511. PubMed ID: 34254615
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.
Michlewska S; Kubczak M; Maroto-Díaz M; Sanz Del Olmo N; Ortega P; Shcharbin D; Gomez Ramirez R; Javier de la Mata F; Ionov M; Bryszewska M
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450702
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium dendrimers as carriers for anticancer siRNA.
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Loznikova S; Shcharbin D; Maly M; Ramirez RG; de la Mata FJ; Bryszewska M
J Inorg Biochem; 2018 Apr; 181():18-27. PubMed ID: 29353086
[TBL] [Abstract][Full Text] [Related]
6. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
Sanz Del Olmo N; Bajo AM; Ionov M; García-Gallego S; Bryszewska M; Gómez R; Ortega P; de la Mata FJ
Eur J Med Chem; 2020 Aug; 199():112414. PubMed ID: 32438200
[TBL] [Abstract][Full Text] [Related]
7. Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro.
Szwed A; Miłowska K; Michlewska S; Moreno S; Shcharbin D; Gomez-Ramirez R; de la Mata FJ; Majoral JP; Bryszewska M; Gabryelak T
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32182909
[TBL] [Abstract][Full Text] [Related]
8. Targeted dendrimers for antagonizing the migration and viability of NALM-6 lymphoblastic leukemia cells.
Chittasupho C; Aonsri C; Imaram W
Bioorg Chem; 2021 Feb; 107():104601. PubMed ID: 33476870
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiation on cytotoxicity, apoptosis and cell cycle arrest of human osteosarcoma MG-63 induced by a ruthenium(II) complex.
Liu SH; Zhao JH; Deng KK; Wu Y; Zhu JW; Liu QH; Xu HH; Wu HF; Li XY; Wang JW; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():202-9. PubMed ID: 25594209
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells.
Wu CF; Hong C; Klauck SM; Lin YL; Efferth T
J Ethnopharmacol; 2015 Dec; 176():55-68. PubMed ID: 26476154
[TBL] [Abstract][Full Text] [Related]
12. Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer.
Sanz Del Olmo N; Maroto-Diaz M; Quintana S; Gómez R; Holota M; Ionov M; Bryszewska M; Carmena MJ; Ortega P; Javier de la Mata F
Eur J Med Chem; 2020 Dec; 207():112695. PubMed ID: 32882608
[TBL] [Abstract][Full Text] [Related]
13. Cell death-inducing properties of selected dendrimers against different breast cancer and leukemia cell lines.
Baecker D; Kapp T; Schumacher P; Gust R; Kircher B
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000209. PubMed ID: 32780524
[TBL] [Abstract][Full Text] [Related]
14. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Novak MS; Büchel GE; Keppler BK; Jakupec MA
J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253
[TBL] [Abstract][Full Text] [Related]
15. The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro.
Ribeiro G; Benadiba M; de Oliveira Silva D; Colquhoun A
Cell Biochem Funct; 2010 Jan; 28(1):15-23. PubMed ID: 19927275
[TBL] [Abstract][Full Text] [Related]
16. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Anticancer Properties of Copper Metallodendrimers.
Hołota M; Magiera J; Michlewska S; Kubczak M; Del Olmo NS; García-Gallego S; Ortega P; de la Mata FJ; Ionov M; Bryszewska M
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31003561
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
[TBL] [Abstract][Full Text] [Related]
19. Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA.
Rodríguez-Prieto T; Michlewska S; Hołota M; Ionov M; de la Mata FJ; Cano J; Bryszewska M; Gómez R
J Inorg Biochem; 2021 Oct; 223():111540. PubMed ID: 34273717
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
